Caffeine is the world’s most popular stimulant and is known to disrupt sleep. Administration of caffeine can therefore be used in healthy volunteers to mimic the effects of insomnia and thus to test the hypnotic effects of medication. This study assessed the effects of caffeine on sleep architecture and electroencephalography (EEG) spectrum alone and in combination with two different sleep-promoting medications. Home polysomnography was performed in 12 healthy male volunteers in a double-blind study whereby subjects received placebo, caffeine (150 mg), caffeine plus zolpidem (10 mg) and caffeine plus trazodone (100 mg) at bedtime in a randomised crossover design. In addition to delaying sleep onset, caffeine decreased total sleep time (TST), sleep efficiency (SE) and stage 2 sleep without significantly altering wake after sleep onset or the number of awakenings. Zolpidem attenuated the caffeine-induced decrease in SE and increased spindle density in the caffeine plus zolpidem combination compared with placebo. Trazodone attenuated the decrease in SE and TST, and it also increased stage 3 sleep, decreased the number of awakenings and decreased the spindle density. No significant changes in rapid eye movement (REM) sleep were observed, neither was any significant alteration in slow wave activity nor other EEG spectral measures, although the direction of change was similar to that previously reported for caffeine and appeared to ‘normalise’ after trazodone. These data suggest that caffeine mimics some, but not all of the sleep disruption seen in insomnia and that its disruptive effects are differentially attenuated by the actions of sleep-promoting compounds with distinct mechanisms of action.
Borbely AA (1982) A two process model of sleep regulation. Hum Neurobiol1: 195–204.
2.
Brunner DP Dijk DJ Munch M Borbely AA (1991) Effect of zolpidem on sleep and sleep EEG spectra in healthy young men. Psychopharmacol104: 1–5.
3.
Cysneiros RM Farkas D Harmatz JS von Moltke LL Greenblatt DJ (2007) Pharmacokinetic and pharmacodynamic interactions between zolpidem and caffeine. Clin Pharmacol Ther82: 54–62.
4.
Drapeau C Hamel-Hebert I Robillard R Selmaoui B Filipini D Carrier J (2006) Challenging sleep in aging: the effects of 200 mg of caffeine during the evening in young and middle-aged moderate caffeine consumers. J Sleep Res15: 133–141.
5.
Fredholm BB (1995) Astra Award Lecture. Adenosine, adenosine receptors and the actions of caffeine. Pharmacol Toxicol76: 93–101.
6.
Fredholm BB Battig K Holmen J Nehlig A Zvartau EE (1999) Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacol Rev51: 83–133.
7.
Haffmans PM Vos MS (1999) The effects of trazodone on sleep disturbances induced by brofaromine. Eur Psychiatry14: 167–171.
8.
Heatherley SV Mullings EL Tidbury MA Rogers PJ (2006) The dietary caffeine and health study: administration of a large postal survey in Bristol. Appetite47: 266–266.
9.
Hicks JA Argyropoulos SV Rich AS Nash JR Bell CJ Edwards C (2002) Randomised controlled study of sleep after nefazodone or paroxetine treatment in out-patients with depression. Br J Psychiatry180: 528–535.
10.
Hindmarch I Rigney U Stanley N Quinlan P Rycroft J Lane J (2000) A naturalistic investigation of the effects of day-long consumption of tea, coffee and water on alertness, sleep onset and sleep quality. Psychopharmacol149: 203–216.
11.
Huang ZL Qu WM Eguchi N Chen JF Schwarzschild MA Fredholm BB (2005) Adenosine A2A, but not A1, receptors mediate the arousal effect of caffeine. Nat Neurosci8: 858–859.
12.
Kanno O Sasaki T Watanabe H Takazawa S Nakagome K Nakajima T (2000) Comparison of the effects of zolpidem and triazolam on nocturnal sleep and sleep latency in the morning: a cross-over study in healthy young volunteers. Prog Neuropsychopharmacol Biol Psychiatry24: 897–910.
13.
Karacan I Thornby JI Anch M Booth GH Williams RL Salis PJ (1976) Dose-related sleep disturbances induced by coffee and caffeine. Clin Pharmacol Ther20: 682–689.
14.
Kaynak H Kaynak D Gozukirmizi E Guilleminault C (2004) The effects of trazodone on sleep in patients treated with stimulant antidepressants. Sleep Med5: 15–20.
15.
Lancel M (1999) Role of GABAA receptors in the regulation of sleep: initial sleep responses to peripherally administered modulators and agonists. Sleep22: 33–42.
16.
Landolt HP (2008) Sleep homeostasis: a role for adenosine in humans? Biochem Pharmacol75: 2070–2079.
17.
Landolt HP Dijk DJ Gaus SE Borbely AA (1995a) Caffeine reduces low-frequency delta activity in the human sleep EEG. Neuropsychopharmacology12: 229–238.
18.
Landolt HP Meier V Burgess HJ Finelli LA Cattelin F Achermann P (1999) Serotonin-2 receptors and human sleep: effect of a selective antagonist on EEG power spectra. Neuropsychopharmacology21: 455–466.
19.
Landolt HP Retey JV Tonz K Gottselig JM Khatami R Buckelmuller I (2004) Caffeine attenuates waking and sleep electroencephalographic markers of sleep homeostasis in humans. Neuropsychopharmacol29: 1933–1939.
20.
Landolt HP Werth E Borbely AA Dijk DJ (1995b) Caffeine intake (200 mg) in the morning affects human sleep and EEG power spectra at night. Brain Res675: 67–74.
21.
Lu J Greco MA (2006) Sleep circuitry and the hypnotic mechanism of GABAA drugs. J Clin Sleep Med2: S19–S26.
22.
Marek GJ McDougle CJ Price LH Seiden LS (1992) A comparison of trazodone and fluoxetine: implications for a serotonergic mechanism of antidepressant action. Psychopharmacology (Berl)109: 2–11.
23.
Mendelson WB (2005) A review of the evidence for the efficacy and safety of trazodone in insomnia. J Clin Psychiatry66: 469–476.
24.
Monti JM Monti D Estevez F Giusti M (1996) Sleep in patients with chronic primary insomnia during long-term zolpidem administration and after its withdrawal. Int Clin Psychopharmacol11: 255–263.
25.
Okuma T Matsuoka H Matsue Y Toyomura K (1982) Model insomnia by methylphenidate and caffeine and use in the evaluation of temazepam. Psychopharmacol76: 201–208.
26.
Owens MJ Morgan WN Plott SJ Nemeroff CB (1997) Neurotransmitter receptor and transporter binding profile of antidepressants and their metabolites. J Pharmacol Exp Ther283: 1305–1322.
27.
Paterson LM Wilson SJ Nutt DJ Hutson PH Ivarsson M (2007) A translational, caffeine-induced model of onset insomnia in rats and healthy volunteers. Psychopharmacol191: 943–950.
28.
Paterson LM Wilson SJ Nutt DJ Hutson PH Ivarsson M (2009) Characterisation of the effects of caffeine on sleep in the rat; a potential model of sleep disruption. J Psychopharmacol23: 475–486.
29.
Porkka-Heiskanen T Strecker RE Thakkar M Bjorkum AA Greene RW McCarley RW (1997) Adenosine: a mediator of the sleep-inducing effects of prolonged wakefulness. Science276: 1265–1268.
30.
Rechtschaffen A Kales A (1968) A manual of standardised terminology, techniques and scoring system for sleep stages in normal subjects.US Dept. Health and Welfare, Washington.
31.
Retey JV Adam M Khatami R Luhmann UF Jung HH Berger W (2007) A genetic variation in the adenosine A2A receptor gene (ADORA2A) contributes to individual sensitivity to caffeine effects on sleep. Clin Pharmacol Ther81: 692–698.
32.
Saletu B (1982) Pharmaco-EEG profiles of typical and atypical antidepressants. Adv Biochem Psychopharmacol32: 257–268.
33.
Saletu-Zyhlarz G Anderer P Brandstatter N Dantendorfer K Gruber G Mandl M (2000) Placebo-controlled sleep laboratory studies on the acute effects of zolpidem on objective and subjective sleep and awakening quality in nonorganic insomnia related to neurotic and stress-related disorder. Neuropsychobiology41: 139–148.
34.
Sharpley AL Solomon RA Fernando AI da Roza Davis JM Cowen PJ (1990) Dose-related effects of selective 5-HT2 receptor antagonists on slow wave sleep in humans. Psychopharmacol101: 568–569.
35.
Stenberg D (2007) Neuroanatomy and neurochemistry of sleep. Cell Mol Life Sci64: 1187–1204.
36.
Suzuki H Yamadera H Nakamura S Endo S (2002) Effects of trazodone and imipramine on the biological rhythm: an analysis of sleep EEG and body core temperature. J Nippon Med Sch69: 333–341.
37.
Tiffin P Ashton H Marsh R Kamali F (1995) Pharmacokinetic and pharmacodynamic responses to caffeine in poor and normal sleepers. Psychopharmacology (Berl)121: 494–502.
38.
Tsutsui S (2001) A double-blind comparative study of zolpidem versus zopiclone in the treatment of chronic primary insomnia. J Int Med Res29: 163–177.
39.
Van Bemmel AL Beersma DG Van den Hoofdakker RH (1995) Changes in EEG power density of non-REM sleep in depressed patients during treatment with trazodone. J Affect Disord35: 11–19.
40.
Voderholzer U Al-Shajlawi A Weske G Feige B Riemann D (2003) Are there gender differences in objective and subjective sleep measures? A study of insomniacs and healthy controls. Depress Anxiety17: 162–172.
41.
Wilson S Argyropoulos S (2005) Antidepressants and sleep: a qualitative review of the literature. Drugs65: 927–947.
42.
Wilson SJ Bailey JE Alford C Nutt DJ (2000) Sleep and daytime sleepiness the next day following single night-time dose of fluvoxamine, dothiepin and placebo in normal volunteers. J Psychopharmacol14: 378–386.
43.
Yamadera H Suzuki H Nakamura S Endo S (1999) Effects of trazodone on polysomnography, blood concentration and core body temperature in healthy volunteers. Psychiatry Clin Neurosci53: 189–191.
